Member Info for dan1nat1

Unfortunately the interview will not be seen by half as many people that have seen the RNS...

Cyno, watch this

http://www.proactiveinvestors.co.uk/companies/stocktube/10466/faron-pharma-to-take-clevegen-cancer-candidate-into-the-clinic-this-year-10466.html

He mentions the other diseases, and some other interesting information.

The buys are starting to build up now...all these 102 trades are buys.

You to Mani, if that interview gets a few views tonight we should be in for a great day tomorrow!

http://www.proactiveinvestors.co.uk/companies/stocktube/10466/faron-pharma-to-take-clevegen-cancer-candidate-into-the-clinic-this-year-10466.html

Mani I'm in, job 1 make a video of the interview and put it on a loop, job 2 make everybody watch it...including Teabiscuit. Job 3 our work here is complete ;)

CB if everything was spelt out in the RNS as clearly as it is in that interview the market reaction would have been totally different!

Confirmed in this interview -

http://www.proactiveinvestors.co.uk/companies/stocktube/10466/faron-pharma-to-take-clevegen-cancer-candidate-into-the-clinic-this-year-10466.html

That interview is fantastic! Teabiscuit probably classes me as one of the boards rampers ;) if everybody watches that I dont even need to bother!

http://www.proactiveinvestors.co.uk/companies/stocktube/10466/faron-pharma-to-take-clevegen-cancer-candidate-into-the-clinic-this-year-10466.html

This is true, I was just pointing out even on the negative side it’s still only 5-6 weeks.

That depends on buying support at the £1 level, it could be strong as we should have a more meaningful update in 5 - 6 weeks.

With an update due in 5-6 weeks, we should be back to yesterday’s level on the run up to them. Today’s RNS didn’t actually have any bad news in that we didn’t already know about. Not a lot to be said other than that really.

Could be, they are only slightly delayed and the reason is probably so they could tweak the trial using the information learned in the European trial.

Today’s drop is well over done, Peel are having a field day, offering at 103 when the next mm is on 109...they really are playing games. Wait for them to go on the bid again, then we should see a more realistic price, based on an RNS that didn’t really tell us anything we didn’t already know.

Someone just got 104.5 for £18k's worth, Peel must be filling or that would have seen the bid drop!

All still to play for imo -

"We believe that the inconsistent biomarker expression may be explained through on going further analysis. We have observed a significant effect on the mortality in the INTEREST trial related to other concurrent and widely used ARDS treatments. Further experiments are ongoing and the results of these and analysis of the INTEREST trial will be presented at the ESICM in October."

And it also looks like there could be other routes to market for Traumakine -

"we also believe that the product has the potential for application in additional disease areas and we initiated a Phase II INFORAAA clinical trial of Traumakine for the treatment of Multi-Organ Failure (MOF) and mortality prevention of surgically repaired Ruptured Abdominal Aortic Aneurysm (RAAA)."

Blue might be pushing it, we had a fairly decent close yesterday. But agreed we are likely to move up from here as people realise this is a great buying opportunity.

I dont, but anything worthy of news would have been in the RNS.

Nothing announced today that we didn't already know, apart from we may have to wait 5-6 weeks for a real Traumakine update. We got a nice strong bounce off £1, so hopefully can stay in our current trading range until the real news lands!

Are you still holding Teabiscuit?

“Our focus for the remainder of 2018 will be to continue to rapidly progress Clevegen through the clinic whilst also continuing to preserve cash in order to deliver value to shareholders. We hope to be able to communicate a new strategy and commercial pathway for Traumakine over the coming months and remain optimistic about our future.”

Traumakine is still in the running to go commercial, looks like we have another 6 weeks or so to wait and find out the plan.

Ideal wording...
“The board is pleased to recommend the takeover bid at £28 per share”